K. Kawashima et al. / Tetrahedron 63 (2007) 1630–1643
1639
4.4.7. (1R*,3S*,3aR*,6aS*)-( )-Methyl 3-[2-(pyrrolidin-
1-yl)-4-oxo-4H-pyrido[1,2-a]pyrimidin-3-yl]-4,6-dioxo-
1,5-diphenylperhydropyrrolo[3,4-c]pyrrole-1-carboxyl-
ate (9c). Colorless crystals from i-PrOH/benzene; mp
223–224 ꢀC; 1H NMR (CDCl3): 1.87–2.04 (4H, br m,
N(CH2CH2)2), 3.67–3.79 (8H, ov, CO2CH3, 3a-H, and
N(CH2CH2)2), 4.64 (1H, dd, J¼9.2, 12.2 Hz, 3-H), 4.74
(1H, d, J¼7.9 Hz, 6a-H), 5.76 (1H, br d, J¼12.2 Hz, ex-
changed with D2O, NH), 6.84 (1H, ddd, J¼1.3, 6.9, 6.9 Hz,
70-H), 7.24–7.40 (9H, ov, 90-H, Ph–H, and NPh–H), 7.51–
7.58 (3H, ov, 80-H and Ph–H), 8.76 (1H, dd, J¼1.0, 6.9 Hz,
60-H); 13C NMR (CDCl3): 25.8, 50.4, 50.7, 53.6, 54.1,
60.0, 89.3, 112.6, 124.4, 126.3, 126.8, 128.1, 128.2, 128.6,
132.5, 135.0, 136.0, 148.3, 158.9, 160.9, 174.0, 174.2,
174.9. Anal. calcd for C32H29N5O5 (563.60): C, 68.19; H,
5.19; N, 12.43. Found: C, 68.03; H, 5.33; N, 12.71.
(1H, br d, J¼12.2 Hz, exchanged with D2O, NH), 7.01
(1H, ddd, J¼1.0, 6.9, 7.1 Hz, 70-H), 7.25–7.45 (9H, ov,
90-H, NPh–H, and Ph–H), 7.53 (2H, dd, J¼1.7, 7.9 Hz,
Ph–H), 7.67 (1H, ddd, J¼1.3, 7.1, 8.3 Hz, 80-H), 8.83 (1H,
dd, J¼1.3, 6.9 Hz, 60-H); 13C NMR (CDCl3): 49.9, 50.4,
53.7, 53.9, 59.9, 66.9, 95.0, 114.4, 125.1, 126.2, 126.7,
128.2, 128.3, 128.34, 128.7, 132.3, 134.6, 136.6, 148.9,
159.5, 164.7, 173.8, 174.7. Anal. calcd for C32H29N5O6
(579.60): C, 66.31; H, 5.04; N, 12.08. Found: C, 66.32;
H, 5.13; N, 11.95.
4.4.11. (1R*,3S*,3aR*,6aS*)-( )-Methyl 3-[2-(N,N-dime-
thylamino)-4-oxo-4H-pyrido[1,2-a]pyrimidin-3-yl]-4,6-
dioxo-5-phenylperhydropyrrolo[3,4-c]-pyrrole-1-carb-
oxylate (8e). White crystals from CH2Cl2/benzene; mp
246–247 ꢀC; IR (KBr): 3298 (NH), 1740, 1701, 1651,
1630 (CO); 1H NMR (CDCl3): 3.14 (6H, s, N(CH3)2), 3.59
(1H, dd, J¼8.6, 8.9 Hz, 6a-H), 3.83–3.89 (4H, ov,
CO2CH3 and 3a-H), 4.08 (1H, dd, J¼7.3, 13.2 Hz, 3-H),
4.57 (1H, dd, J¼8.9, 13.2 Hz, 1-H), 4.79 (1H, dd, J¼13.2,
13.2 Hz, exchanged with D2O, NH), 6.89 (1H, ddd, J¼1.3,
6.6, 6.6 Hz, 70-H), 7.31–7.45 (6H, ov, 90-H and NPh–H),
7.58 (1H, ddd, J¼1.7, 6.6, 7.8 Hz, 80-H), 8.79 (1H, br d,
J¼6.6 Hz, 60-H); 13C NMR (CDCl3): 41.7, 49.3, 51.4,
52.4, 61.9, 63.1, 91.6, 113.2, 124.6, 126.9, 127.0, 128.4,
128.9, 132.5, 136.3, 148.4, 159.0, 164.7, 169.8, 175.0,
175.4. Anal. calcd for C24H23N5O5 (461.47): C, 62.46; H,
5.02; N, 15.18. Found: C, 62.35; H, 4.92; N, 15.16.
4.4.8. (1R*,3S*,3aS*,6aR*)-( )-Methyl 3-[2-(pyrrolidin-
1-yl)-4-oxo-4H-pyrido[1,2-a]pyrimidin-3-yl]-4,6-dioxo-
1,5-diphenylperhydropyrrolo[3,4-c]pyrrole-1-carboxyl-
ate (10c). Colorless crystals from i-PrOH/benzene; mp 217–
218 ꢀC; 1H NMR (CDCl3): 1.86–1.96 (4H, br m,
N(CH2CH2)2), 3.61 (3H, s, CO2CH3), 3.80–3.83 (4H, br m,
N(CH2CH2)2), 4.15 (1H, d, J¼10.2 Hz, 6a-H), 4.37 (1H, br
d, J¼8.3 Hz, exchanged with D2O, NH), 4.55 (1H, dd,
J¼6.9, 10.2 Hz, 3a-H), 5.15 (1H, br s, 3-H), 6.81 (1H, ddd,
J¼1.3, 7.3, 7.3 Hz, 70-H), 7.25–7.57 (10H, ov, 80-H, 90-H,
Ph–H, and NPh–H), 7.88 (2H, d, J¼6.9 Hz, Ph–H), 8.70
(1H, br d, J¼7.3 Hz, 60-H); 13C NMR (CDCl3): 26.2, 50.8,
52.1, 53.5, 58.9, 59.3, 91.5, 112.8, 125.0, 126.2, 127.1,
127.6, 128.5, 128.8, 129.0, 129.5, 132.9, 136.4, 140.8,
148.9, 158.8, 160.0, 173.1, 175.9, 177.9. Anal. calcd for
C32H29N5O5 (563.60): C, 68.19; H, 5.19; N, 12.43. Found:
C, 68.09; H, 5.33; N, 12.24.
4.4.12. (1R*,3R*,3aR*,6aS*)-( )-Methyl 3-[2-(N,N-di-
methylamino)-4-oxo-4H-pyrido[1,2-a]pyrimidin-3-yl]-
4,6-dioxo-5-phenylperhydropyrrolo[3,4-c]pyrrole-1-
carboxylate (10e). Colorless crystals from benzene/i-PrOH;
mp 226–227 ꢀC; 1H NMR (CDCl3): 3.16 (6H, s, N(CH3)2),
3.65 (1H, dd, J¼8.6, 8.9 Hz, 6a-H), 3.82 (3H, s, CO2CH3),
3.99 (1H, dd, J¼1.0, 8.6 Hz, 3a-H), 4.63 (1H, br s, 3-H),
4.74–4.77 (2H, ov, NH and 1-H), 6.87 (1H, ddd, J¼1.3,
6.9, 6.9 Hz, 70-H), 7.30–7.48 (6H, ov, 90-H and NPh–H),
7.57 (1H, ddd, J¼1.7, 6.9, 6.9 Hz, 80-H), 8.71 (1H, br d,
J¼6.9 Hz, 60-H); 13C NMR (CDCl3): 41.6, 48.9, 52.1,
52.7, 62.0, 63.4, 90.9, 113.2, 124.6, 126.6, 126.8, 128.3,
128.9, 132.6, 136.2, 148.3, 159.0, 164.5, 172.7, 175.5,
177.1. Anal. calcd for C24H23N5O5 (461.47): C, 62.46; H,
5.02; N, 15.18. Found: C, 62.51; H, 4.96; N, 14.88.
4.4.9. (1R*,3R*,3aS*,6aR*)-( )-Methyl 3-(2-morpholino-
4-oxo-4H-pyrido[1,2-a]pyrimidin-3-yl)-4,6-dioxo-1,5-di-
phenylperhydropyrrolo[3,4-c]pyrrole-1-carboxylate
(8d). This compound was obtained as a (2:1) molecular com-
plex with benzene after recrystallization. White powders
from hexane/benzene; mp 196–197 ꢀC; IR (KBr): 3267
1
(NH), 1734, 1714, 1659, 1632 (CO); H NMR (CDCl3):
3.28–3.59 (9H, ov, N(CH2CH2)2O and 3a-H), 3.79 (3H, s,
CO2CH3), 4.29 (1H, dd, J¼9.2, 13.2 Hz, 3-H), 4.39 (1H, d,
J¼7.9 Hz, 6a-H), 5.36 (1H, d, J¼13.2 Hz, exchanged with
D2O, NH), 6.98 (1H, ddd, J¼1.0, 6.9, 6.9 Hz, 70-H), 7.33–
7.50 (12H, ov, 90-H, NPh–H, Ph–H, and 1/2C6H6), 7.64
(1H, ddd, J¼1.7, 6.6, 6.6 Hz, 80-H), 7.75 (2H, dd, J¼1.3,
7.6 Hz, Ph–H), 8.82 (1H, br d, J¼6.9 Hz, 60-H); 13C NMR
(CDCl3): 49.7, 50.4, 53.1, 55.9, 59.0, 66.7, 94.6, 114.3,
125.0, 126.9, 127.0, 127.1, 128.3, 128.46, 128.54, 128.9,
132.5, 136.5, 139.2, 149.0, 159.4, 164.7, 170.6, 175.0,
175.4. Anal. calcd for C35H32N5O6 (618.66): C, 67.95; H,
5.21; N, 11.32. Found: C, 67.98; H, 5.23; N, 11.23.
4.4.13. (1R*,3S*,3aR*,6aS*)-( )-Methyl 1-methyl-3-[2-
(N,N-dimethylamino)-4-oxo-4H-pyrido[1,2-a]pyrimidin-
3-yl]-4,6-dioxo-5-phenylperhydropyrrolo[3,4-c]pyrrole-
1-carboxylate (8f). Colorless crystals from i-PrOH/benz-
ene; mp 245–246 ꢀC; IR (KBr): 3286 (NH), 1736, 1705,
1
1655, 1630 (CO); H NMR (CDCl3): 1.62 (3H, s, CH3),
3.12 (6H, s, N(CH3)2), 3.54 (1H, d, J¼8.3 Hz, 6a-H), 3.66
(1H, dd, J¼8.3, 9.2 Hz, 3a-H), 3.85 (3H, s, CO2CH3), 4.75
(1H, dd, J¼9.2, 13.2 Hz, 3-H), 5.29 (1H, br d, J¼13.2 Hz,
exchanged with D2O, NH), 6.86 (1H, ddd, J¼1.3, 6.6,
6.9 Hz, 70-H), 7.26–7.44 (7H, ov, 90-H and NPh–H), 7.56
(1H, ddd, J¼1.0, 6.9, 8.2 Hz, 80-H), 8.78 (1H, dd, J¼1.0,
6.6 Hz, 60-H); 13C NMR (CDCl3): 24.2, 41.6, 49.3,
52.7, 57.9, 60.2, 68.3, 91.6, 113.1, 124.5, 126.9, 127.0,
128.3, 128.8, 132.5, 136.2, 148.3, 159.0, 164.7, 172.1,
175.0, 175.3. Anal. calcd for C25H25N5O5 (475.50):
C, 63.15; H, 5.30; N, 14.73. Found: C, 63.39; H, 5.32;
N, 14.68.
4.4.10. (1R*,3S*,3aR*,6aS*)-( )-Methyl 3-(2-morpho-
lino-4-oxo-4H-pyrido[1,2-a]pyrimidin-3-yl)-4,6-dioxo-
1,5-diphenylperhydropyrrolo[3,4-c]pyrrole-1-carboxyl-
ate (9d). Colorless crystals from i-PrOH/benzene; mp
213–214 ꢀC; 1H NMR (CDCl3): 3.46–3.60 (4H, ov,
N(CH2CH2)2O), 3.67 (1H, dd, J¼7.9, 8.9 Hz, 3a-H), 3.77–
3.83 (7H, ov, CO2CH3 and N(CH2CH2)2O), 4.53 (1H, dd,
J¼8.9, 12.2 Hz, 3-H), 4.76 (1H, d, J¼7.9 Hz, 6a-H), 5.34